Predicting responsiveness to GLP-1 pathway drugs using real-world data
Zhu X, Fowler MJ, Wells QS, et al.
BMC Endocr Disord. 2024;24(1):269.
Leggi
Zhu X, Fowler MJ, Wells QS, et al.
BMC Endocr Disord. 2024;24(1):269.
Leggi
Karges B, Rosenbauer J, Stahl-Pehe A, et al.
Lancet Diabetes Endocrinol. 2024:S2213-8587(24)00284-5.
Leggi
Wang Y, Lu J, Yu J, et al.
Diabetes Obes Metab. Pub. online 18 Dec 2024.
Leggi
Stefan N, Yki-Järvinen H, Neuschwander-Tetri BA
Lancet Diabetes Endocrinol. Pub. online 13 Dec 2024.
Leggi
Gargouri I, Charfi H, Belabed W, et al.
Diabetes Obes Metab. Pub. online 17 Dec 2024.
Leggi
Barnard-Kelly K, Marrero D, de Wit M, et al. Diabet Med. 2024:e15484 Abstract
Leggi
Immanuel J, Cheung NW, Mohajeri M, et al.
Diabetes Care. 2024:dc241199
Leggi
Butt JH, Henderson AD, Jhund PS, et al.
J Am Coll Cardiol. 2024:S0735-1097(24)10423-8.
Leggi
Franceschi R, Pertile R, Marigliano M, et al.
Diabetes Res Clin Pract. 2024:111962.
Leggi
Redondo MJ, Cuthbertson D, Steck AK, et al.
Diabetologia. Pub. online 13 Dec 2024.
Leggi